Who owns CONMED Corp (CNMD)? Elite investor 13F holders

5 tracked elite investors reported holding CONMED Corp as of 2026-06-30, including Oaktree Capital Management, D.E. Shaw, GAMCO, Gotham Asset Management, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Oaktree Capital ManagementCONMED CORPSHARE2026-06-302026-08-14 00:00:0052464810.00 USD53645000.000000PrincipaladdOriginal filing
D.E. ShawCONMED CORPSHARE2026-06-302026-08-14 00:00:002230026.00 USD68134.000000SharesaddOriginal filing
GAMCOCONMED CORPSHARE2026-06-302026-08-12 00:00:001872156.00 USD57200.000000SharesholdOriginal filing
Gotham Asset ManagementCONMED CORPSHARE2026-06-302026-08-14 00:00:00489379.00 USD14952.000000SharesreduceOriginal filing
Tudor InvestmentCONMED CORPSHARE2026-06-302026-08-14 00:00:00762707.00 USD23303.000000SharesbuyOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown